Dr. Varvara Boryushkina, MD

Dr. Boryushkina practices at Long Island Digestive Endoscopy Center, LLC in Port Jefferson Station, New York.

Dr. Boryushkina's NPI, 1164927661, was assigned on March 27, 2018. Dr. Boryushkina holds New York license 312976-01.

Dr. Boryushkina's primary practice is Long Island Digestive Endoscopy Center, LLC, at 1500 State Rte 112, Port Jefferson Station, NY 11776 in Suffolk County. The practice phone is (631) 828-3400.

Dr. Boryushkina's primary practice is Long Island Digestive Endoscopy Center, LLC in Port Jefferson Station, New York. Dr. Boryushkina is also affiliated with Mather Hospital. The medical group on file is Mather Medical Group. Dmand AI also links Dr. Boryushkina to 1 more hospital, 4 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boryushkina practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Boryushkina's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Boryushkina is board certified in internal medicine by the American Board of Internal Medicine. Dr. Boryushkina is licensed in New York.

CMS data shows 1,772 Medicare services from Dr. Boryushkina across 14 procedure codes in 2024, for 282 Medicare patients. Medicare paid $94,938 for them. Every service was in an office.

CMS counts 282 Medicare patients who saw Dr. Boryushkina in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boryushkina's median patient age at 61, with 65% women.

In 2024, Dr. Boryushkina wrote 4,441 Medicare Part D claims for 434 patients. 89% of them were for generic drugs. CMS names the drug for 3,796 of them, across 90 drugs with 11 or more claims each, at $358,119 in total drug cost. In 2023, CMS named 1,710 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Boryushkina for performance year 2024, reported through an alternative payment model (APM). Dr. Boryushkina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boryushkina as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Boryushkina from 2 drug and device companies from 2021 to 2022. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $123.

Dr. Boryushkina is in network with 15 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.